Aptose Biosciences Inc (APS) — Cash Flow-to-Debt Ratio
Aptose Biosciences Inc (APS) has a Cash Flow-to-Debt Ratio of -0.29x as of September 2025, meaning its operating cash flow of CA$-7.41 Million could theoretically repay 0% of its total liabilities (CA$25.79 Million) in one year. See Aptose Biosciences Inc free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Aptose Biosciences Inc Cash Flow-to-Debt Ratio (1996–2024)
Historical debt coverage capacity for Aptose Biosciences Inc across 29 annual periods. Also explore how fast is Aptose Biosciences Inc growing its equity to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Aptose Biosciences Inc (1996–2024)
Year-by-year debt coverage analysis for Aptose Biosciences Inc. For market capitalisation and broader financial context, see Aptose Biosciences Inc (APS) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -2.45x | CA$-35.98 Million | CA$14.67 Million | ▲ +12.6% |
| 2023 | -2.81x | CA$-44.59 Million | CA$15.89 Million | ▼ -15.3% |
| 2022 | -2.43x | CA$-32.32 Million | CA$13.29 Million | ▲ +53.4% |
| 2021 | -5.22x | CA$-43.30 Million | CA$8.29 Million | ▼ -13.3% |
| 2020 | -4.61x | CA$-33.89 Million | CA$7.35 Million | ▼ -40.2% |
| 2019 | -3.29x | CA$-21.56 Million | CA$6.55 Million | ▲ +60.4% |
| 2018 | -8.32x | CA$-23.21 Million | CA$2.79 Million | ▼ -43.7% |
| 2017 | -5.79x | CA$-10.22 Million | CA$1.76 Million | ▲ +37.3% |
| 2016 | -9.24x | CA$-12.17 Million | CA$1.32 Million | ▼ -59.0% |
| 2015 | -5.81x | CA$-9.89 Million | CA$1.70 Million | ▼ -17.5% |
| 2014 | -4.95x | CA$-9.94 Million | CA$2.01 Million | ▼ -76.5% |
| 2013 | -2.80x | CA$-4.94 Million | CA$1.76 Million | ▼ -127.0% |
| 2012 | -1.23x | CA$-3.21 Million | CA$2.60 Million | ▲ +75.7% |
| 2011 | -5.09x | CA$-6.03 Million | CA$1.19 Million | ▼ -288.8% |
| 2010 | -1.31x | CA$-3.53 Million | CA$2.70 Million | ▼ -187.9% |
| 2009 | -0.45x | CA$-6.62 Million | CA$14.57 Million | ▲ +31.1% |
| 2008 | -0.66x | CA$-10.25 Million | CA$15.55 Million | ▼ -54.2% |
| 2007 | -0.43x | CA$-5.88 Million | CA$13.76 Million | ▲ +54.1% |
| 2006 | -0.93x | CA$-11.87 Million | CA$12.73 Million | ▲ +28.8% |
| 2005 | -1.31x | CA$-14.92 Million | CA$11.40 Million | ▲ +0.0% |
| 2004 | -1.31x | CA$-14.92 Million | CA$11.40 Million | ▲ +72.8% |
| 2003 | -4.82x | CA$-20.60 Million | CA$4.28 Million | ▼ -38.8% |
| 2002 | -3.47x | CA$-7.79 Million | CA$2.25 Million | ▲ +0.0% |
| 2001 | -3.47x | CA$-7.79 Million | CA$2.25 Million | ▼ -110.6% |
| 2000 | -1.65x | CA$-6.28 Million | CA$3.81 Million | ▼ -10.9% |
| 1999 | -1.49x | CA$-3.58 Million | CA$2.41 Million | ▲ +46.3% |
| 1998 | -2.77x | CA$-2.44 Million | CA$881.66K | ▲ +30.8% |
| 1997 | -4.00x | CA$-3.02 Million | CA$755.18K | ▼ -22.2% |
| 1996 | -3.27x | CA$-2.61 Million | CA$798.14K | — |